Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 11/2014

01-11-2014 | Psychiatric Management of Pain (M Clark, Section Editor)

Suicide by Means of Opioid Overdose in Patients with Chronic Pain

Authors: Parvaz Madadi, Nav Persaud

Published in: Current Pain and Headache Reports | Issue 11/2014

Login to get access

Abstract

Deaths from prescription opioid use continue to rise in North America. The main focus to date has been developing strategies to prevent nonintentional (accidental) fatalities, which constitute the majority of opioid deaths across all jurisdictions. Often overlooked is the complex group of individuals whose cause of death was suicide by opioid overdose. Although most opioid prescribing tools focus on identifying risk factors for potential abuse, diversion, and propensity for opioid addiction, physicians who consider prescribing opioids should also screen and optimize chronic pain treatment for patients at risk for suicide.
Literature
1.
Fischer B, Jones W, Urbanoski K, Skinner R, Rehm J. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Drug Alcohol Rev. 2014;33:19–26.PubMedCrossRef
2.
Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;17:686–91.
3.
Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q. 2011;14:22–4.PubMedCrossRef
4.
Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract. 2014;27:5–16.PubMedCrossRef
5.
6.
Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.PubMedCrossRefPubMedCentral
7.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminaryvalidation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–42.
8.
Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360–72.PubMedCrossRefPubMedCentral
9.
Furlan AD, Reardon R, Salach L. The opioid manager: a point-of-care tool to facilitate the use of the Canadian Opioid Guideline. J Opioid Manag. 2012;8:57–61.PubMedCrossRef
10.
Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613–20.PubMedCrossRef
11.
Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305:1346–7.PubMedCrossRef
12.
Madadi P, Hildebrandt D, Lauwers AE, Koren G. Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada. PLoS ONE. 2013;8:e60600.PubMedCrossRefPubMedCentral
13.
Siegler A, Tuazon E, Bradley O’Brien D, Paone D. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk. Int J Drug Policy. 2014;25:569–74.PubMedCrossRef
14.
Johnson EM, Lanier WA, Merrill RM, Crook J, Porucznik CA, Rolfs RT, et al. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009. J Gen Intern Med. 2013;28:522–9.PubMedCrossRefPubMedCentral
15.
Piercefield E, Archer P, Kemp P, Mallonee S. Increase in unintentional medication overdose deaths: Oklahoma, 1994-2006. Am J Prev Med. 2010;39:357–63.PubMedCrossRef
16.
Centers for Disease Control and Prevention (CDC). Drug overdose deaths—Florida, 2003-2009. Morb Mortal Wkly Rep. 2011;60:869–72.
17.
Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87–95.PubMedCrossRef
18.
Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Morb Mortal Wkly Rep. 2012;61:10–3.
19.
Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181:891–6.PubMedCrossRefPubMedCentral
20.
21.
22.
Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657–9.PubMedCrossRef
23.•
Sinyor M, Howlett A, Cheung AH, Schaffer A. Substances used in completed suicide by overdose in Toronto: an observational study of coroner’s data. Can J Psychiatry. 2012;57:184–91. This article contains an overview of common substances used in completed suicides and offers a recommendation related to prescribing these substances to at-risk patients.PubMed
24.
Centers for Disease Control and Prevention (CDC). Toxicology testing and results for suicide victims—13 states, 2004. Morb Mortal Wkly Rep. 2006;55:1245–8.
25.
Shields LB, Hunsaker DM, Hunsaker III JC, Ward MK. Toxicologic findings in suicide: a 10-year retrospective review of Kentucky medical examiner cases. Am J Forensic Med Pathol. 2006;27:106–12.PubMedCrossRef
26.
Hassett AL, Aquino JK, Ilgen MA. The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep. 2014;18:436.PubMed
27.
Tang NK, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med. 2006;36:575–86.PubMedCrossRef
28.
Cheatle MD, Wasser T, Foster C, Olugbodi A, Bryan J. Prevalence of suicidal ideation in patients with chronic non-cancer pain referred to a behaviorally based pain program. Pain Phys. 2014;17:E359–67.
29.•
Ilgen MA, Kleinberg F, Ignacio RV, Bohnert AS, Valenstein M, McCarthy JF, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry. 2013;70:692–7. This article identifies specific pain conditions associated with the greatest risk of suicide after controlling for concurrent psychiatric diagnoses.PubMedCrossRef
30.
Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31:564–70.PubMedCrossRefPubMedCentral
31.
Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119:95–103.PubMedCrossRef
32.
Haibach JP, Beehler GP, Dollar KM, Finnell DS. Moving toward integrated behavioral intervention for treating multi-morbidity among chronic pain, depression, and substance-use disorders in primary care. Med Care. 2014;52:322–7.PubMedCrossRef
33.
Bohnert AS, Roeder KM, Ilgen MA. Unintentional overdose and suicide amongst substance abusers: a review of overlap and risk factors. Drug Alcohol Depend. 2010;110:183–92.PubMedCrossRef
34.
Kuramoto SJ, Chilcoat HD, Ko J, Martins SS. Suicidal ideation and suicide attempt across stages of nonmedical prescription opioid use and presence of prescription opioid disorders among U.S. adults. J Stud Alcohol Drugs. 2012;73:178–84.PubMedPubMedCentral
35.
Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1, CD006605.PubMed
36.••
Cheatle MD. Depression, chronic pain, and suicide by overdose: on the edge. Pain Med. 2011;12 Suppl 2:S43–8. A holistic commentary on the intersection of depression, chronic pain, and suicide. This piece also discusses possible mediators of suicidal ideation, risk assessment, mental health screening, and strategies for intervention.PubMedCrossRefPubMedCentral
Metadata
Title
Suicide by Means of Opioid Overdose in Patients with Chronic Pain
Authors
Parvaz Madadi
Nav Persaud
Publication date
01-11-2014
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 11/2014
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-014-0460-1

Other articles of this Issue 11/2014

Current Pain and Headache Reports 11/2014 Go to the issue

Migraine (R Cowan, Section Editor)

Migraine is Associated With Altered Processing of Sensory Stimuli

Secondary Headache (K Henry and M Robbins, Section Editors)

Headache Secondary to Intracranial Hypotension

Neuropathic Pain (E Eisenberg, Section Editor)

Cancer Treatment-Related Neuropathic Pain Syndromes—Epidemiology and Treatment: An Update

Fibromyalgia (M Peres, Section Editor)

Restless Legs Syndrome and Pain Disorders: What’s in common?

Migraine (R Cowan, Section Editor)

Update on Animal Models of Migraine